Profs Rachelle Buchbinder and Chris Maher share their thoughts on how big pharma creates markets and influences organisations and government - profit-driven healthcare in the age of too much medicine.
Forty-one per cent of cancers detected by PSA screening can be classed as overdiagnosis, researchers say. Overdiagnosis of prostate cancer is a concern across the developed world, but researchers from Bond University say they are the first to quantify the problem in Australia.
More than 40 per cent of prostate cancers detected by basic screening tests are overdiagnosed in Australia, potentially leading to unnecessary treatments.
Professor Paul Glasziou, Bond University, says that we know that quite a lot of cancers are these dormant cancers that never would have disturbed the person in their lifetime... the most common complication would be impotence... Associate Professor David Smith, Cancer Council NSW, says we [...]
New Australian research suggests many men are being diagnosed with prostate cancer and potentially receiving unnecessary treatment. Bond University researchers have found too many men are getting invasive treatment, when more than 40 per cent of them wouldn't end up needing it.
The lifetime risk of being diagnosed with prostate cancer increased from 6.1% in 1982 (1 in 17) to 19.6% in 2012 (1 in 5). Using 2012 competing mortality rates, the lifetime risk in 1982 was 11.5% (95% CI 11.0% to 12.0%). The excess lifetime risk [...]
Jodie won the 2019 award for the top-ranked Career Development Fellowship (Clinical) application
With Wiser Healthcare's A/Prof Jesse Jansen
1 in 4 Australians experiences low back pain on any given day. But research shows active recovery can help you find relief.
Sarah lives in London. She is pregnant with her first child. Her mother had gestational diabetes and Sarah is told this puts her into a higher risk category for the condition, thus she should have a test...